Safety and pharmacokinetics of sirolimus-eluting stents in the canine cerebral vasculature: 180 Day assessment

Neurosurgery

Volumn 59, Issue 4, 2006, Pages 925-933

  Levy, Elad I ^a,b   Hanel, Ricardo A ^b   Tio, Fermin O ^c   Garlick, David S ^d   Bailey, Lynn ^d   Cunningham, Mark R ^d   Williard, Clark ^e   Sherman, Darren ^f   Dooley, John F ^g   Kopia, Gregory A ^b,g  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d CHARLES RIVER LABORATORIES   (United States)

^e Taylor Technology Inc   (United States)

^f Cordis Corporation ^*  (United States)

^g Department of Medical Affairs and Health Ecomomics Worldwide   (United States)

Author keywords

Angioplasty; Arteries (cerebral); Pharmacology; Revascularization; Stents

Indexed keywords

RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY THROMBOSIS; ARTICLE; BASILAR ARTERY; BRAIN BLOOD VESSEL; BRAIN INFARCTION; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG ELUTING STENT; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GLIOSIS; INFLAMMATION; LOW DRUG DOSE; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR PATENCY;

ANIMALS; CEREBRAL ARTERIES; CEREBRAL INFARCTION; DOGS; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; FEMALE; GLIOSIS; INFARCTION; MALE; SIROLIMUS; SPINAL CORD; STENTS; TIME FACTORS; VASCULAR PATENCY;

EID: 33750057354     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000233777.46522.1E     Document Type: Article

References (40)

1. Al-Shahi R, Warlow C: A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain 124:1900-1926, 2001.
2. American Society of Interventional and Therapeutic Neuroradiology: Angioplasty and stenting of extracranial brachiocephalic stenoses (other than the cervical carotid bifurcation) and intracranial stenoses. AJNR Am J Neuroradiol 22 [Suppl]:S31-S33, 2001.
3. Chaturvedi S, Caplan LR: Angioplasty for intracranial atherosclerosis: Is the treatment worse than the disease? Neurology 61:1647-1648, 2003.
4. Choi JH, Mohr JP: Brain arteriovenous malformations in adults. Lancet 4:299-308, 2005.
5. Connors JJ 3rd, Wojak JC: Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: Evolution of technique and short-term results. J Neurosurg 91:415-423, 1999.
6. Craig DR, Meguro K, Watridge C, Robertson JT, Barnett HJ, Fox AJ: Intracranial internal carotid artery stenosis. Stroke 13:825-828, 1982.
7. de Rochemont Rdu M, Turowski B, Buchkremer M, Sitzer M, Zanella FE, Berkefeld J: Recurrent symptomatic high-grade intracranial stenoses: Safety and efficacy of undersized stents: Initial experience. Radiology 231:45-49, 2004.
8. Engh JA, Levy EI, Howington JU, Guterman LR: Intracranial angioplasty and stenting: Modern approaches to revascularization for atherosclerotic disease. Neurosurg Clin N Am 16:297-308, 2005.
9. Gallo R, Padurean A, Jayaraman T, Marx S, Roque M, Adelman S, Chesebro J, Fallon J, Fuster V, Marks A, Badimon JJ: Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 99:2164-2170, 1999.
10. Hartmann M, Jansen O: Angioplasty and stenting of intracranial stenosis. Curr Opin Neurol 18:39-45, 2005.
11. Higashida RT: Intracranial stenting: Which patients and when? Cleve Clin J Med 71 [Suppl]:S50-S51, 2004.
12. International Study of Unruptured Intracranial Aneurysms Investigators: Unruptured intracranial aneurysms-Risk of rupture and risks of surgical intervention. N Engl J Med 339:1725-1733, 1998.
13. Jiang WJ, Wang YJ, Du B, Wang SX, Wang GH, Jin M, Dai JP: Stenting of symptomatic M1 stenosis of middle cerebral artery: An initial experience of 40 patients. Stroke 35:1375-1380, 2004.
14. Kereiakes DJ: Coronary small-vessel stenting in the era of drug elution. Rev Cardiovasc Med 2 [Suppl]:S34-S45, 2004.
15. Kim JK, Ahn JY, Lee BH, Chung YS, Chung SS, Kim OJ, Kim WC, Joo JY: Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: Short term arteriographical and clinical outcome. J Neurol Neurosurg Psychiatry 75:847-851, 2004.
16. Kirken RA, Wang YL: Molecular actions of sirolimus: Sirolimus and mTor. Transplant Proc 35 [Suppl 3]:227S-230S, 2003.
17. Kopia GA, Snead D, Falotico R, Lauer M, Fischell T, Devries J, Carter AJ, Tio F, Hulsebos L, Turck P, Snodgrass J, Dooley J: Pharmacokinetics and pharmacodynamics of sirolimus-eluting stents. Am J Cardiol 90 [Suppl 6A]: 115H, 2002.
18. Lee TH, Kim DH, Lee BH, Kim HJ, Choi CH, Park KP, Jung DS, Kim S, Moon TY: Preliminary results of endovascular stent-assisted angioplasty for symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol 26:166-174, 2005.
19. Levy EI, Hanel RA, Bendok BR, Boulos AS, Hartney ML, Guterman LR, Qureshi AI, Hopkins LN: Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis. J Neurosurg 97:1294-1301, 2002.
20. Levy EI, Hanel RA, Boulos AS, Bendok BR, Kim SH, Gibbons KJ, Qureshi AI, Guterman LR, Hopkins LN: Comparison of periprocedure complications resulting from direct stent placement compared with those due to conventional and staged stent placement in the basilar artery. J Neurosurg 99:653-660, 2003.
21. Levy EI, Hanel RA, Howington JU, Nemes B, Boulos AS, Tio FO, Paciorek AM, Amlani S, Kagan-Hallett KS, Fronckowiak MD, Guterman LR, Hopkins LN: Sirolimus-eluting stents in the canine cerebral vasculature: A prospective, randomized, blinded assessment of safety and vessel response. J Neurosurg 100:688-694, 2004.
22. Lylyk P, Cohen JE, Ceratto R, Ferrario A, Miranda C: Angioplasty and stent placement in intracranial atherosclerotic stenoses and dissections. AJNR Am J Neuroradiol 23:430-436, 2002.
23. Malek AM, Higashida RT, Phatouros CC, Lempert TE, Meyers PM, Gress DR, Dowd CF, Halbach VV: Treatment of posterior circulation ischemia with extracranial percutaneous balloon angioplasty and stent placement. Stroke 30:2073-2085, 1999.
24. Mori T, Kazita K, Chokyu K, Mima T, Mori K: Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol 21:249-254, 2000.
25. Mori T, Kazita K, Mori K: Cerebral angioplasty and stenting for intracranial vertebral atherosclerotic stenosis. AJNR Am J Neuroradiol 20:787-789, 1999.
26. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R: A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773-1780, 2002.
27. Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, Lee CW, Choi D, Jang Y, Lam R, Weissman NJ, Mintz GS: A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 348:1537-1545, 2003.
28. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR: Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 98:2277-2283, 1996.
29. Sacco RL, Kargman DE, Gu Q, Zamanillo MC: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 26:14-20, 1995.
30. Serkova N, Christians U, Flogel U, Pfeuffer J, Leibfritz D: Assessment of the mechanism of astrocyte swelling induced by the macrolide immunosuppressant sirolimus using multinuclear nuclear magnetic resonance spectroscopy. Chem Res Toxicol 10:1359-1363, 1997.
31. Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pinto IM, Seixas AC, Staico R, Mattos LA, Sousa AG, Falotico R, Jaeger J, Popma JJ, Serruys PW: Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103:192-195, 2001.
32. Sousa JE, Costa MA, Abizaid A, Feres F, Seixas AC, Tanajura LF, Mattos LA, Falotico R, Jaeger J, Popma JJ, Serruys PW, Sousa AG: Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation 111:2326-2329, 2005.
33. Sousa JE, Costa MA, Sousa AG, Abizaid AC, Seixas AC, Abizaid AS, Feres F, Mattos LA, Falotico R, Jaeger J, Popma JJ, Serruys PW: Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 107:381-383, 2003.
34. SSYLVIA Study Investigators: Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): Study results. Stroke 35:1388-1392, 2004.
35. Sundt TM Jr, Smith HC, Campbell JK, Vlietstra RE, Cucchiara RF, Stanson AW: Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc 55:673-680, 1980.
36. Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky R, Klugherz BD, Papandreou G, Narayan P, Leon MB, Yeung AC, Tio F, Tsao PS, Falotico R, Carter AJ: Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104:1188-1193, 2001.
37. Thijs VN, Albers GW: Symptomatic intracranial atherosclerosis: Outcome of patients who fail antithrombotic therapy. Neurology 55:490-497, 2000.
38. Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group: Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke 29:1389-1392, 1998.
39. Wiebers DO, Whisnant JP, Huston J 3rd, Meissner I, Brown RD Jr, Piepgras DG, Forbes GS, Thielen K, Nichols D, O'Fallon WM, Peacock J, Jaeger L, Kassell NF, Kongable-Beckman GL, Torner JC, International Study of Unruptured Intracranial Aneurysms Investigators: Unruptured intracranial aneurysms: Natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 362:103-110, 2003.
40. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B: Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 27:1974-1980, 1996.